HF
ALAB icon

HRT Financial’s Astera Labs ALAB Stock Holding History

HRT Financial’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.31M Buy
+21,100
New +$3.01M 0.01% 1522

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

HRT Financial's ALAB Position: Q2 2025 in Review

HRT Financial sold out of Astera Labs (ALAB) in Q2 2025, closing a stake of 31,536 shares — an estimated $1.88M sold.

HRT Financial first reported a position in ALAB in Q3 2024 and held it in 2 quarters. The position peaked at $23.8M in Q3 2024. 513 funds tracked by Wall St. Rank hold ALAB as of Q2 2025.

  • HRT Financial reported no remaining Astera Labs position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 31,536 Astera Labs shares in Q2 2025, an estimated $1.88M.
  • HRT Financial first reported a position in Astera Labs in Q3 2024 and held it in 2 quarters.
  • HRT Financial's Astera Labs position peaked at $23.8M in Q3 2024.
  • 513 funds tracked by Wall St. Rank held Astera Labs as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.